Your browser doesn't support javascript.
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial.
Hannawi, Suad; Saifeldin, Linda; Abuquta, Alaa; Alamadi, Ahmad; Mahmoud, Sally A; Li, Jian; Chen, Yuanxin; Xie, Liangzhi.
  • Hannawi S; Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates.
  • Saifeldin L; General Surgery Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates.
  • Abuquta A; Internal Medicine Department, Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates.
  • Alamadi A; Ear, Nose and Throat Department (ENT), Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, United Arab Emirates.
  • Mahmoud SA; Biogenix labs, G42 Healthcare, Dubai, United Arab Emirates.
  • Li J; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Chen Y; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Xie L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China; Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing China. Electronic address: LX@sinocelltech.com.
J Infect ; 86(2): 154-225, 2023 02.
Article in English | MEDLINE | ID: covidwho-2150126
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Language: English Journal: J Infect Year: 2023 Document Type: Article Affiliation country: J.jinf.2022.12.003

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Language: English Journal: J Infect Year: 2023 Document Type: Article Affiliation country: J.jinf.2022.12.003